Abstract
Humans serve as both host and reservoir for Mycobacterium tuberculosis, making tuberculosis a theoretically eradicable disease. How M. tuberculosis alternates between host-imposed quiescence and sporadic bouts of replication to complete its life cycle, however, remains unknown. Here, we identify a metabolic adaptation that is triggered upon entry into hypoxia-induced quiescence but facilitates subsequent cell cycle re-entry. Catabolic remodelling of the cell surface trehalose mycolates of M. tuberculosis specifically generates metabolic intermediates reserved for re-initiation of peptidoglycan biosynthesis. These adaptations reveal a metabolic network with the regulatory capacity to mount an anticipatory response.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Russell, D. G., Barry, C. E. III & Flynn, J. L. Tuberculosis: what we don't know can, and does, hurt us. Science 328, 852–856 (2010).
Blaser, M. J. & Kirschner, D. The equilibria that allow bacterial persistence in human hosts. Nature 449, 843–849 (2007).
Rustad, T. R., Sherrid, A. M., Minch, K. J. & Sherman, D. R. Hypoxia: a window into Mycobacterium tuberculosis latency. Cell Microbiol. 11, 1151–1159 (2009).
Lakshminarayana, S. B. et al. Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents. J. Antimicrob. Chemother. 70, 857–867 (2015).
Warner, D. F. & Mizrahi, V. Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy. Clin. Microbiol. Rev. 19, 558–570 (2006).
Watanabe, S. et al. Fumarate reductase activity maintains an energized membrane in anaerobic mycobacterium tuberculosis. PLoS Pathog. 7, e1002287 (2011).
Eoh, H. & Rhee, K. Y. Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 110, 6554–6559 (2013).
Ortega, C. et al. Mycobacterium tuberculosis Ser/Thr protein kinase B mediates an oxygen-dependent replication switch. PLoS Biol. 12, e1001746 (2014).
Ortega, C. et al. Systematic survey of serine hydrolase activity in Mycobacterium tuberculosis defines changes associated with persistence. Cell Chem. Biol. 23, 290–298 (2016).
Schubert, O. T. et al. Absolute proteome composition and dynamics during dormancy and resuscitation of Mycobacterium tuberculosis. Cell Host Microbe. 18, 96–108 (2015).
Kalscheuer, R. & Koliwer-Brandl, H. Genetics of mycobacterial trehalose metabolism. Microbiol. Spectr. http://dx.doi.org/10.1128/microbiolspec.MGM2-0002-2013 (2014).
Ishikawa, E. et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J. Exp. Med. 206, 2879–2888 (2009).
Galagan, J. E. et al. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 499, 178–183 (2013).
Kalscheuer, R. et al. Self-poisoning of Mycobacterium tuberculosis by targeting GlgE in an α-glucan pathway. Nat. Chem. Biol. 6, 376–384 (2010).
Miah, F. et al. Flux through trehalose synthase flows from trehalose to the alpha anomer of maltose in mycobacteria. Chem. Biol. 20, 487–493 (2013).
Stincone, A. et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol. Rev. Camb. Philos. Soc. 90, 927–963 (2015)
Walsh, C. T., Benson, T. E., Kim, D. H. & Lees, W. J. The versatility of phosphoenolpyruvate and its vinyl ether products in biosynthesis. Chem. Biol. 3, 83–91 (1996).
De Smet, K. A. et al. Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis. Microbiology 145, 3177–3184 (1999).
Venturelli, O. S., Zuleta, I., Murray, R. M. & El-Samad, H. Population diversification in a yeast metabolic program promotes anticipation of environmental shifts. PLoS Biol. 13, e1002042 (2015).
Mitchell, A. et al. Adaptive prediction of environmental changes by microorganisms. Nature 460, 220–224 (2009).
Tagkopoulos, I., Liu, Y. C. & Tavazoie, S. Predictive behavior within microbial genetic networks. Science 320, 1313–1317 (2008).
Warner, D. F. Mycobacterium tuberculosis metabolism. Cold Spring Harb. Perspect. Med. 5, pii.a021121 (2015).
Rao, S. P., Alonso, S., Rand, L., Dick, T. & Pethe, K. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 105, 11945–11950 (2008).
Boutte, C. C. et al. A cytoplasmic peptidoglycan amidase homologue controls mycobacterial cell wall synthesis. eLife 5, e14590 (2016).
Backus, K. M. et al. The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions. J. Biol. Chem. 289, 25041–25053 (2014).
van Heerden, J. H. et al. Lost in transition: start-up of glycolysis yields subpopulations of nongrowing cells. Science 343, 1245114 (2014).
Lenaerts, A., Barry, C. E. III & Dartois, V. Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol. Rev. 264, 288–307 (2015).
De Carvalho, L. P. et al. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem. Biol. 17, 1122–1131 (2010).
Layre, E. et al. A comparative lipidomics platform for chemotaxonomic analysis of Mycobacterium tuberculosis. Chem. Biol. 18, 1537–1549 (2011).
Ehrt, S. et al. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194, 1123–1140 (2001).
Acknowledgements
The authors thank G. Rehren and D. Schnappinger for advice in constructing knockout strains, C. Nathan, J. Vaubourgeix, S. Ehrt and S. Tavazoie for critical discussions and reading of the manuscript, S. Fischer for expert mass spectrometric support and the Bill and Melinda Gates Foundation Grand Challenges Exploration Program (OPP1068025) and National Institutes of Health Tri-I TBRU (U19-AI11143) for support.
Author information
Authors and Affiliations
Contributions
H.E. and Z.W. designed, conducted and analysed metabolomic profiling studies. E.L. and D.B.M. conducted and analysed lipidomic profiling studies. H.E. and P.R. conducted macrophage cytokine release assays. H.E., Z.W. and R.M. conducted antibiotic susceptibility assays. K.Y.R. initiated and directed this research.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Figures 1–8. (PDF 1539 kb)
Supplementary Data 1
All relevant source data related to metabolomic and lipidomic data shown in Figures 1–4 and Supplementary Figures 1–8. (XLSX 103 kb)
Rights and permissions
About this article
Cite this article
Eoh, H., Wang, Z., Layre, E. et al. Metabolic anticipation in Mycobacterium tuberculosis. Nat Microbiol 2, 17084 (2017). https://doi.org/10.1038/nmicrobiol.2017.84
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/nmicrobiol.2017.84
This article is cited by
-
Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci
Scientific Reports (2022)
-
Mechanisms controlling bacterial infection in myeloid cells under hypoxic conditions
Cellular and Molecular Life Sciences (2021)
-
Repositioning of Isatin hybrids as novel anti-tubercular agents overcoming pre-existing antibiotics resistance
Medicinal Chemistry Research (2021)
-
The mycobacterial cell envelope — a moving target
Nature Reviews Microbiology (2020)
-
Comparative label-free lipidomic analysis of Mycobacterium tuberculosis during dormancy and reactivation
Scientific Reports (2019)